Novo Nordisk, Eli Lilly roll out obesity pills, prepare for Medicare coverage
Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as…
Novo Nordisk rolls out Wegovy pill in the UAE — its first market outside the U.S.
Novo Nordisk is launching its weight loss pill Wegovy in the United Arab Emirates, the Danish drugmaker said…
CVS restores Zepbound coverage, adds Eli Lilly’s obesity pill Foundayo
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on…
Eli Lilly weight loss drug retatrutide clears obesity trial
Eli Lilly on Thursday said its next-generation drug cleared a crucial late-stage trial in patients with obesity, delivering…
Global market reordering is accelerating as the AI rally gains pace
The Wall Street bull stands in the financial district near the New York Stock Exchange on Nov. 18,…
New data boosts our confidence in Lilly’s obesity pill. Plus, Google’s new AI
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Novo Nordisk releases new high-dose Wegovy data
A Wegovy injection pen shown in Waterbury, Vermont, April 28, 2025. Shelby Knowles | Bloomberg | Getty Images…
Leadership challenge swirls around Starmer
U.K. Prime Minister Keir Starmer leaves Downing Street on February 02, 2026 in London, United Kingdom. Alishia Abodunde…
Novo Nordisk faces Ozempic generics in Canada
Ozempic is medicine for adults with type 2 diabetes that along with diet and exercise may improve blood…
Social media reshapes world’s fastest-growing consumer market
Hello, this is Priyanka Salve, writing to you from Singapore. Welcome to the latest edition of “Inside India” — your…
FDA proposes excluding Novo, Lilly GLP-1s from compounding list
The headquarters of the U.S. Food and Drug Administration in Silver Spring, Maryland, Nov. 4, 2009. Jason Reed…
20,000 people taking drug, Ricks says
More than 20,000 people have started taking Eli Lilly‘s GLP-1 pill Foundayo in its first few weeks on…